Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel

Tim Kanters, Jelena Stevanovic, I Huys, Arnold Vulto, S Simoens

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)
1 Downloads (Pure)
Original languageUndefined/Unknown
Article number322
JournalFrontiers in Pharmacology
Publication statusPublished - 2017

Cite this